IPLab:Lab 13:Myelomeningocele
Contents
Clinical SummaryEdit
This male fetus of a 21-year-old Rh-positive mother (Gravida 2 Para 1011) was the product of an induced delivery at 21 weeks gestation. At 19 weeks gestation, routine prenatal examination had revealed a maternal serum alpha-fetoprotein (AFP) level that was 4.2 times the mean for a mother at this point in gestation. A targeted ultrasound was ordered--which revealed a lumbosacral neural tube defect--and an amniocentesis was performed. Amniotic fluid showed an AFP level that was 5.3 times the calculated median value and cytogenetic analysis demonstrated a normal male (46XY) chromosome pattern. The parents requested termination of the pregnancy and a 465-gram male nondysmorphic stillborn fetus was delivered vaginally.
At autopsy there was a myelomeningocele in the lumbar region that measured 1.6 cm in width and 3.7 cm in length.
ImagesEdit
This is a gross photograph of the fetus at autopsy. Note the defect in the lower lumbar region of the spinal column (arrow). The myelomeningocele can be seen protruding from this defect.
This gross photograph shows consecutive lumbar vertebra from this case. Note the defect (arrows) in the two vertebral bodies on the right. This defect was caused by failure of the vertebral column to properly close.
This is a closer view of the previous gross photograph showing a normal lumbar vertebra from this case on the left. Once again, note the defect (arrow) in the vertebral body on the right due to failure of the vertebral column to close properly.
This is a low-power photomicrograph of one of the vertebral bodies from this case. In this section there are defects (arrows) in the vertebral body but the skin can be seen over the open vertebral canal.
This is a higher-power photomicrograph of one of the vertebral bodies from this case. The defect (arrows) in the vertebral body is seen more clearly. The spinal cord is disrupted and there are areas of hemorrhage in this region.
This is a high-power photomicrograph of the spinal cord (arrow) immediately beneath the area of hemorrhage.
This high-power photomicrograph of the spinal cord within the vertebral column shows the hemorrhage (arrows) in this region.
Study QuestionsEdit
Additional ResourcesEdit
ReferenceEdit
- eMedicine Medical Library: Spina Bifida
- eMedicine Medical Library: Neural Tube Defects in the Neonatal Period
- eMedicine Medical Library: Neural Tube Defects
- Merck Manual: Multifactorial (Complex) Inheritance
- Merck Manual: Spina Bifida
Journal ArticlesEdit
- Cortes RA, Farmer DL. Recent advances in fetal surgery. Semin Perinatol 2004 Jun;28(3):199-211.
ImagesEdit
Rh-positive infants of Rh-negative mothers are at particular risk of developing erythroblastosis fetalis (hemolytic disease of newborns) unless preventive treatments are administered. Successful screening for maternal Rh-negativity and subsequent preventive treatment has greatly reduced the incidence of Rh-induced erythroblastosis fetalis. However, ABO incompatibility between the mother and fetus can also cause erythroblastosis fetalis. Thus, the fact that this mother was Rh-positive does not protect the fetus from developing ABO-induced incompatibility if the mother and fetus have different ABO blood types.
Gravida and para are forms of Latin words which are used in clinical notation. Gravida indicates the number of pregnancies which a woman has had (including a current pregnancy). Thus a pregnant woman with two previous pregnancies (regardless of the outcomes of the pregnancies) would be considered Gravida 3 (abbreviated G3). Para indicates the outcomes of a woman's pregnancies. It is represented by four numbers. First number: term births. Second number: preterm births. Third number: abortions. Fourth number: living children. A woman who is currently pregnant and who has had two previous pregnancies--one child being born preterm and the other term, both now living--would be listed as G3 P1102. A current pregnancy is not included because the outcome is not yet known.
The normal gestation period is 38 to 42 weeks.
Alpha-fetoprotein (AFP) is a serum glycoprotein produced during pregnancy by the yolk sac, fetal GI tract, and fetal liver. Elevated serum AFP levels in a pregnant woman can be an indication of a fetal neural tube defect (or something as common as multiple pregnancy). Open fetal neural tube defects allow alpha-fetoprotein to leak into the amniotic fluid, from which it crosses the placenta and enters the maternal bloodstream. Elevated maternal AFP is an indication for amniocentesis (of which an AFP level of amniotic fluid is routine) and an ultrasound. The combination of these two tests are very reliable in detecting neural tube defects.
Alpha-fetoprotein (AFP) is a serum glycoprotein produced during pregnancy by the yolk sac, fetal GI tract, and fetal liver. Elevated serum AFP levels in a pregnant woman can be an indication of a fetal neural tube defect (or something as common as multiple pregnancy). Decreased serum levels are indicative of trisomy 21.
A maternal serum AFP level is considered elevated if it is greater than 2.5 times the mean.
The neural plate is a part of the dorsal ectoderm from which the central nervous system develops. During fetal development, this plate folds longitudinally to form the neural tube which is protected by the eventual development of surrounding mesoderm into the skull, vertebral column, and skin. A neural tube defect occurs when this surrounding mesoderm does not properly enclose around the neural tube.
Amniocentesis is a procedure in which a needle is inserted transabdominally through the uterus, into the amniotic sac, and amniotic fluid is withdrawn.
A normal male fetus at this age of development should weigh 360 to 492 grams.
A myelomeningocele is the herniation of the spinal cord--within the meninges--through a defect in the vertebral canal.